Skip to content

Clinical trials

Acute Coronary Syndrome trials in Hong Kong

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Acute Coronary Syndrome Country / region: Hong Kong Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20061
20081
20092
20101
20131
20141
20181
20191
20221
20252

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed7
Terminated2
Not yet recruiting1
Recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Chinese University of Hong Kong3
The University of Hong Kong2
AstraZeneca1
CSL Behring1
GlaxoSmithKline1
Novartis Pharmaceuticals1
Sanofi1
Takeda1
University of Oxford1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Acute Coronary Syndrome12
Myocardial Infarction4
Diabetes Mellitus, Type 23
Stroke3
Cardiovascular Diseases2
Coronary Artery Disease2
Non-ST Elevated Myocardial Infarction2
ST Elevation Myocardial Infarction2
Anemia1
Angina, Unstable1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.